Advances of pharmacological therapies in lipodystrophy syndromes: current evidence and future directions
{{output}}
Introduction: Lipodystrophy syndromes are a heterogeneous group of rare disorders characterized by partial or generalized loss of adipose tissue, which may be either inherited or acquired. Loss of adipose tissue in typical storag... ...
